Evidence map›Paper›PMID 25521608›Full record

ArticlePLoS neglected tropical diseases2014

Characterization of the Ca2+-gated and voltage-dependent K+-channel Slo-1 of nematodes and its interaction with emodepside.

Daniel Kulke, Georg von Samson-Himmelstjerna, Sandra M Miltsch, Adrian J Wolstenholme, Aaron R Jex, Robin B Gasser, Cristina Ballesteros, Timothy G Geary, Jennifer Keiser, Simon Townson and 2 more

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
6.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 53 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Diethylcarbamazine elicits CaAntimicrobial agents and chemotherapy · 2023
    Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Evaluation of the in vitro susceptibility of various filarial nematodes to emodepside.International journal for parasitology. Drugs and drug resistance · 2021
    Article
  13. Review
  14. Natural variation in Caenorhabditis elegans responses to the anthelmintic emodepside.International journal for parasitology. Drugs and drug resistance · 2021
    Article
  15. Article
  16. Review
  17. Article
  18. Caenorhabditis elegans in anthelmintic research - Old model, new perspectives.International journal for parasitology. Drugs and drug resistance · 2020
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 8 institutions in 6 countries.

Daniel KulkeInstitute for Parasitology and Tropical Veterinary Medicine, Freie Universität Berlin, Berlin, Germany; Global Drug Discovery, Animal Health, Parasiticides, Bayer HealthCare, Leverkusen, Germany.
Georg von Samson-HimmelstjernaInstitute for Parasitology and Tropical Veterinary Medicine, Freie Universität Berlin, Berlin, Germany.
Sandra M MiltschInstitute for Parasitology and Tropical Veterinary Medicine, Freie Universität Berlin, Berlin, Germany.
Adrian J WolstenholmeDepartment of Infectious Diseases, College of Veterinary Medicine, The University of Georgia, Athens, Georgia, United States of America.
Aaron R JexFaculty of Veterinary Science, The University of Melbourne, Parkville, Victoria, Australia.
Robin B GasserFaculty of Veterinary Science, The University of Melbourne, Parkville, Victoria, Australia.
Cristina BallesterosInstitute of Parasitology, McGill University, Sainte-Anne-de-Bellevue, Quebec, Canada.
Timothy G GearyInstitute of Parasitology, McGill University, Sainte-Anne-de-Bellevue, Quebec, Canada.
Jennifer KeiserDepartment of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland.
Simon TownsonTropical Parasitic Diseases Unit, Northwick Park Institute for Medical Research, Harrow, Middlesex, United Kingdom.
Achim HarderWE Biology, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany.
Jürgen KrückenInstitute for Parasitology and Tropical Veterinary Medicine, Freie Universität Berlin, Berlin, Germany.
Freie Universität Berlin · DEMcGill University · CAUniversity of Melbourne · AUBayer (Germany) · DEHeinrich Heine University Düsseldorf · DENorthwick Park Institute for Medical Research · GBSwiss Tropical and Public Health Institute · CHUniversity of Georgia · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The cyclooctadepsipeptide emodepside and its parent compound PF1022A are broad-spectrum nematicidal drugs which are able to eliminate nematodes resistant to other anthelmintics. The mode of action of cyclooctadepsipeptides is only partially understood, but involves the latrophilin Lat-1 receptor and the voltage- and calcium-activated potassium channel Slo-1. Genetic evidence suggests that emodepside exerts its anthelmintic activity predominantly through Slo-1. Indeed, slo-1 deficient Caenorhabditis elegans strains are completely emodepside resistant. However, direct effects of emodepside on Slo-1 have not been reported and these channels have only been characterized for C. elegans and related Strongylida. Molecular and bioinformatic analyses identified full-length Slo-1 cDNAs of Ascaris suum, Parascaris equorum, Toxocara canis, Dirofilaria immitis, Brugia malayi, Onchocerca gutturosa and Strongyloides ratti. Two paralogs were identified in the trichocephalids Trichuris muris, Trichuris suis and Trichinella spiralis. Several splice variants encoding truncated channels were identified in Trichuris spp. Slo-1 channels of trichocephalids form a monophyletic group, showing that duplication occurred after the divergence of Enoplea and Chromadorea. To explore the function of a representative protein, C. elegans Slo-1a was expressed in Xenopus laevis oocytes and studied in electrophysiological (voltage-clamp) experiments. Incubation of oocytes with 1-10 µM emodepside caused significantly increased currents over a wide range of step potentials in the absence of experimentally increased intracellular Ca2+, suggesting that emodepside directly opens C. elegans Slo-1a. Emodepside wash-out did not reverse the effect and the Slo-1 inhibitor verruculogen was only effective when applied before, but not after, emodepside. The identification of several splice variants and paralogs in some parasitic nematodes suggests that there are substantial differences in channel properties among species. Most importantly, this study showed for the first time that emodepside directly opens a Slo-1 channel, significantly improving the understanding of the mode of action of this drug class.

Indexed as

AnimalsAnthelminticsCaenorhabditis elegansCaenorhabditis elegans ProteinsCalciumDepsipeptidesLarge-Conductance Calcium-Activated Potassium ChannelsPatch-Clamp TechniquesPhylogenyXenopus laevisAnthelminticsCaenorhabditis elegans ProteinsCalciumDepsipeptidesemodepsideLarge-Conductance Calcium-Activated Potassium Channelsslo-1 protein, C elegans

Identifiers

PMID25521608
PMCPMC4270693
OpenAlexW2074661823

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.